Polaryx Therapeutics, Inc. PLYX Stock Issuance Proceeds
Stock Issuance Proceeds at other companies
Other financials
Where this comes from
Reported directly by Polaryx Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:ProceedsFromIssuanceOfCommonStock.
The official record: Polaryx Therapeutics, Inc. ’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →
Ask your AI about Polaryx Therapeutics, Inc. 's stock issuance proceeds.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Polaryx Therapeutics, Inc. 's stock issuance proceeds?
- Polaryx Therapeutics, Inc. (PLYX) reported stock issuance proceeds of $250K in Q1 2025.
- How has Polaryx Therapeutics, Inc. 's stock issuance proceeds changed year-over-year?
- Polaryx Therapeutics, Inc. 's stock issuance proceeds decreased by 86.3% year-over-year, from $1.83M to $250K.
- What does stock issuance proceeds mean?
- Cash received from issuing common stock — IPOs, secondary offerings, DRIP, employee stock purchase plans, and option exercises.